Ramesh Vishwakarma

923 total citations
46 papers, 411 citations indexed

About

Ramesh Vishwakarma is a scholar working on Infectious Diseases, Neurology and Epidemiology. According to data from OpenAlex, Ramesh Vishwakarma has authored 46 papers receiving a total of 411 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Infectious Diseases, 14 papers in Neurology and 12 papers in Epidemiology. Recurrent topics in Ramesh Vishwakarma's work include COVID-19 Clinical Research Studies (17 papers), Long-Term Effects of COVID-19 (11 papers) and Sepsis Diagnosis and Treatment (9 papers). Ramesh Vishwakarma is often cited by papers focused on COVID-19 Clinical Research Studies (17 papers), Long-Term Effects of COVID-19 (11 papers) and Sepsis Diagnosis and Treatment (9 papers). Ramesh Vishwakarma collaborates with scholars based in Saudi Arabia, United Kingdom and Belgium. Ramesh Vishwakarma's co-authors include Vivek Verma, Dilip C. Nath, Hafiz T. A. Khan, Khalid Al Sulaiman, Ohoud Aljuhani, Shmeylan Al Harbi, Aisha Alharbi, Ram Prakash, Anita Verma and Hisham A. Badreldin and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Ramesh Vishwakarma

42 papers receiving 401 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ramesh Vishwakarma Saudi Arabia	10	141	73	65	62	53	46	411
Tammy H. Cummings United States	10	386 2.7×	33 0.5×	169 2.6×	117 1.9×	46 0.9×	38	683
Zhaoyan Chen China	15	91 0.6×	25 0.3×	26 0.4×	55 0.9×	21 0.4×	50	564
Aynishet Adane Ethiopia	12	97 0.7×	63 0.9×	23 0.4×	101 1.6×	10 0.2×	28	445
Thomas J. Best United States	11	247 1.8×	227 3.1×	67 1.0×	26 0.4×	11 0.2×	21	656
Pablo García United States	13	152 1.1×	12 0.2×	24 0.4×	75 1.2×	33 0.6×	33	532
Gabriel Patarroyo‐Aponte United States	13	427 3.0×	90 1.2×	201 3.1×	86 1.4×	17 0.3×	32	657
Fahad Gul United States	12	364 2.6×	84 1.2×	173 2.7×	75 1.2×	12 0.2×	19	650
Zurab Azmaiparashvili United States	11	406 2.9×	88 1.2×	186 2.9×	73 1.2×	12 0.2×	30	585
Jeri Albano United States	10	385 2.7×	89 1.2×	174 2.7×	64 1.0×	12 0.2×	16	557
Aksel Karl Georg Jensen Denmark	15	46 0.3×	45 0.6×	7 0.1×	128 2.1×	24 0.5×	50	613

Countries citing papers authored by Ramesh Vishwakarma

Since Specialization

Citations

This map shows the geographic impact of Ramesh Vishwakarma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ramesh Vishwakarma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ramesh Vishwakarma more than expected).

Fields of papers citing papers by Ramesh Vishwakarma

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ramesh Vishwakarma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ramesh Vishwakarma. The network helps show where Ramesh Vishwakarma may publish in the future.

Co-authorship network of co-authors of Ramesh Vishwakarma

This figure shows the co-authorship network connecting the top 25 collaborators of Ramesh Vishwakarma. A scholar is included among the top collaborators of Ramesh Vishwakarma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ramesh Vishwakarma. Ramesh Vishwakarma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Aljuhani, Ohoud, Khalid Al Sulaiman, Ghazwa B. Korayem, et al.. (2024). The association between tocilizumab therapy and the development of thrombosis in critically ill patients with COVID-19: a multicenter, cohort study. Scientific Reports. 14(1). 3037–3037. 4 indexed citations

Aljuhani, Ohoud, Khalid Al Sulaiman, Ghazwa B. Korayem, et al.. (2024). Ketamine-based Sedation Use in Mechanically Ventilated Critically Ill Patients with COVID-19: A Multicenter Cohort Study. Saudi Pharmaceutical Journal. 32(5). 102061–102061. 1 indexed citations

Aljuhani, Ohoud, Ghazwa B. Korayem, Ali F. Altebainawi, et al.. (2023). The effect of oseltamivir use in critically ill patients with COVID-19: A multicenter propensity score-matched study. Saudi Pharmaceutical Journal. 31(7). 1210–1218. 1 indexed citations

Aljuhani, Ohoud, Khalid Al Sulaiman, Ghazwa B. Korayem, et al.. (2023). The use of Tocilizumab in COVID-19 critically ill patients with renal impairment: a multicenter, cohort study. Renal Failure. 45(2). 2268213–2268213. 3 indexed citations

Sulaiman, Khalid Al, et al.. (2022). The correlation between non-O blood group type and recurrent catheter-associated urinary tract infections in critically ill patients: A retrospective study. Journal of International Medical Research. 50(7). 3629169010–3629169010. 4 indexed citations

Sulaiman, Khalid Al, et al.. (2022). Impact of Ursodeoxycholic Acid in Critically Ill Patients With Sepsis: A Retrospective Study. Journal of Pharmacy Practice. 36(3). 566–571. 1 indexed citations

Sulaiman, Khalid Al, et al.. (2021). Appropriateness of Using Vitamin K for the Correction of INR Elevation Secondary to Hepatic Disease in Critically ill Patients: An Observational Study. Clinical and Applied Thrombosis/Hemostasis. 27. 2975232427–2975232427. 5 indexed citations

Sulaiman, Khalid Al, Ohoud Aljuhani, Khalid Eljaaly, et al.. (2021). Clinical features and outcomes of critically ill patients with coronavirus disease 2019 (COVID-19): A multicenter cohort study. International Journal of Infectious Diseases. 105. 180–187. 34 indexed citations

Saleh, Khalid Bin, Khalid Al Sulaiman, Ohoud Aljuhani, et al.. (2021). Clinical characteristics and outcomes of patients with heart failure admitted to the intensive care unit with coronavirus disease 2019 (COVID-19): A multicenter cohort study. SHILAP Revista de lepidopterología. 7. 100033–100033. 4 indexed citations

10.

Sulaiman, Khalid Al, Abdulrahman Alshaya, Ohoud Aljuhani, et al.. (2021). The impact of early target attainment of vancomycin in critically ill patients with confirmed Gram-positive infection: A retrospective cohort study. BMC Infectious Diseases. 21(1). 1182–1182. 5 indexed citations

11.

Sulaiman, Khalid Al, Ohoud Aljuhani, Asma M. Alshahrani, et al.. (2021). Evaluation of thiamine as adjunctive therapy in COVID-19 critically ill patients: a two-center propensity score matched study. Critical Care. 25(1). 223–223. 24 indexed citations

12.

Sulaiman, Khalid Al, Ohoud Aljuhani, Ghazwa B. Korayem, et al.. (2021). Single versus multiple doses of Tocilizumab in critically ill patients with coronavirus disease 2019 (COVID-19): A two-center, retrospective cohort study. Journal of Critical Care. 66. 44–51. 5 indexed citations

13.

Sulaiman, Khalid Al, Ohoud Aljuhani, Khalid Bin Saleh, et al.. (2021). Ascorbic acid as an adjunctive therapy in critically ill patients with COVID-19: a propensity score matched study. Scientific Reports. 11(1). 17648–17648. 41 indexed citations

14.

Hazwani, Tarek, et al.. (2021). Association between platelet count and multiorgan dysfunction and outcomes in patients with sepsis in the pediatric intensive care unit in Saudi Arabia. Journal of Infection and Public Health. 14(11). 1585–1589. 1 indexed citations

15.

Aljuhani, Ohoud, Khalid Al Sulaiman, Khalid Eljaaly, et al.. (2021). Association between tocilizumab and emerging multidrug-resistant organisms in critically ill patients with COVID-19: A multicenter, retrospective cohort study. BMC Infectious Diseases. 21(1). 1127–1127. 6 indexed citations

16.

Verma, Vivek, Ramesh Vishwakarma, Anita Verma, Dilip C. Nath, & Hafiz T. A. Khan. (2020). Time-to-Death approach in revealing Chronicity and Severity of COVID-19 across the World. PLoS ONE. 15(5). e0233074–e0233074. 22 indexed citations

17.

Verma, Vivek, et al.. (2020). Prevalence and determinants of caesarean section in South and South-East Asian women. PLoS ONE. 15(3). e0229906–e0229906. 60 indexed citations

18.

Kumar, Amit, Shubham Misra, Vivek Verma, et al.. (2020). Global impact of environmental temperature and BCG vaccination coverage on the transmissibility and fatality rate of COVID-19. PLoS ONE. 15(10). e0240710–e0240710. 14 indexed citations

19.

Hazwani, Tarek, et al.. (2020). Association Between Culture-Negative Versus Culture-Positive Sepsis and Outcomes of Patients Admitted to the Pediatric Intensive Care Unit. Cureus. 12(8). e9981–e9981. 18 indexed citations

20.

Rashid, Mamoon, et al.. (2019). Molecular classification of colorectal cancer using the gene expression profile of tumor samples. Experimental Biology and Medicine. 244(12). 1005–1016. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact